To the Editor In the March issue of JAMA Oncology, Melisko and colleagues1 published their randomized trial. We are concerned that their registration was delayed and their article is an example of selective outcome reporting.2
First, the investigation was initiated in October 2007 but registered with ClinicalTrials.gov 8 months later (June 2008).
Tang W, Zhang Y. Concerns About Methodology of a Trial Investigating Vaginal Health During Aromatase Inhibitor Therapy for Breast Cancer. JAMA Oncol. 2017;3(8):1140–1141. doi:10.1001/jamaoncol.2017.2071
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: